Kuros Biosciences CEO and key executive team

• Michael Grau

  Chief Financial Officer
• Joost De Bruijn

  Chief Executive Officer, Director
• Alistair Irvine

  Chief Business Officer
• Philippe Saudan

  Chief Development Officer
• Pascal Longlade

  Chief Medical Officer
• Scott Bruder

  Non-Executive Director
• Charlie Campion

  SVP, Marketing & International Sales
• Clemens Van Blitterswijk

  Chairman
• Florence Barrère De Groot

  Head of Development
• John Griffin

  SVP & President, US Sales
• Oliver Walker

  Non-Executive Director
• Katherine Sage

  Vice President, Medical Affairs, Director of Scientific Affairs
• James Ryaby

  SVP, Clinical and Medical Affairs
• Chris Fair

  Chief Operating Officer
• Marcel Borger

  Head of Quality & Regulatory Affairs
• Leanna Caron

  Vice Chair

Source: kuros.ch, kuros.ch, kuros.ch, kurosbio.com